Siemens releases powerful MR gradients

Article

Siemens Medical Systems this month announced the introduction of its new Quantum gradients as an option to users of the Iselin, NJ, vendor's Symphony 1.5-tesla and Harmony 1-tesla MRI scanners. The powerful gradients will serve as a platform for

Siemens Medical Systems this month announced the introduction of its new Quantum gradients as an option to users of the Iselin, NJ, vendor's Symphony 1.5-tesla and Harmony 1-tesla MRI scanners. The powerful gradients will serve as a platform for exploring new clinical applications for MRI, according to Hermann Requardt, president of the company's MR business unit.

The Quantum gradients are rated at 30 mtesla/m with a peak 125 tesla/m/sec slew rate and maximum 50-cm field-of-view. Achieving such specifications while maintaining the 60-cm apertures of the Symphony and Harmony magnet bores is a major accomplishment, the company said. Siemens believes that the gradients will improve clinical imaging parameters by 25% to 50%.

The gradients were featured in the MRI section of Siemens' booth at this month's European Congress of Radiology in Vienna. They require 510(k) certification from the Food and Drug Administration and thus are not yet commercially available in the U.S.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.